Avacta Group plc
("Avacta" or "the Company")
Exercise of Warrants
The Company announces that on 4 January 2011 it received a notice of exercise
of warrants. The warrants were granted during May 2006, prior to the reversal
of Avacta Limited into the Company, then named Readybuy plc. The warrants have
been exercised in respect of 10,500,000 Ordinary shares of 0.1p par value (the
"New Ordinary shares") in the capital of the Company at an exercise price of £
0.0025. As a result, the Company now has 1,447,073,289 Ordinary shares in
issue.
Application is to be made for the New Ordinary shares, which will rank pari
passu with existing ordinary shares, to be admitted to trading on AIM, and
Admission is expected to take place on 11 January 2011.
Enquiries:
Avacta Group plc Tel: 0844 414 0452
Alastair Smith, Chief Executive Officer
Tim Sykes, Chief Financial Officer
Broker - XCAP Securities Plc Tel: 020 7101 7070
John Grant/Karen Kelly/David Newton
NOMAD - Grant Thornton Corporate Finance Tel: 020 7383 5100
Philip Secrett/Colin Aaronson/David Hignell
PR - NexFin
Nicholas Nelson Tel: 07921 522 920
nicholas.nelson@nexfin.co
The Company's website is www.avacta.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.